Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2026-02-01 @ 9:18 PM
Study NCT ID:
NCT05619692
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2022-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
Sponsor:
Supernus Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-09
First Submit QC Date:
None
Study First Post Date:
2022-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-03
Results First Submit QC Date:
None
Results First Post Date:
2025-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-15
Last Update Post Date Type:
ESTIMATED